Anand Shah

Adjunct Professor of Medical Ethics and Health Policy
Department: Medical Ethics and Health Policy
Education:
BS (Economics)
Duke University, 2001.
MD
University of Pennsylvania, 2008.
MPH
Harvard School of Public Health, 2008.
Permanent linkBS (Economics)
Duke University, 2001.
MD
University of Pennsylvania, 2008.
MPH
Harvard School of Public Health, 2008.
Selected Publications
Farber MB and Shah A: The FDA is at a crossroads for reducing tobacco-related disease and death. STAT 2022.Kadakia KT, Pazdur R, Shah A: US Food and Drug Administration support for oncology drug development during COVID-19. JAMA Oncol 2021.
Shah A: Medicare needs to OK rule giving seniors access to FDA-approved medical devices. CNBC 2021.
Kadakia KT and Shah A: Addressing antimicrobial resistance – the invisible pandemic. Health Affairs Forefront 2021.
Shah A, Marks P, Hahn S: Ensuring the safety and effectiveness of a COVID-19 vaccine. Health Affairs Forefront 2020.
Shah A, Kadakia KT, Marks P, Cavazzoni P, Hahn S: FDA initiatives to accelerate the development of COVID-19 therapeutics. Health Affairs Forefront 2020.
Shah A, Shuren J, Hahn S: FDA support for expedited access to COVID-19 diagnostics. Health Affairs Forefront 2020.
Shah A and Hahn S: The FDA response to COVID-19 at six months: regulatory innovation in the face of a pandemic. Health Affairs Forefront 2020.
Hahn S and Shah A: Coronavirus vaccine search – here’s what we’re doing to defeat COVID-19. FOX News 2020.
Kadakia KT, Patel B, Shah A: Advancing digital health: FDA innovation during COVID-19. npj Digital Medicine 2020.